Skip to main content
. Author manuscript; available in PMC: 2014 Apr 15.
Published in final edited form as: Cancer Res. 2013 Feb 19;73(8):2435–2444. doi: 10.1158/0008-5472.CAN-12-3381

Figure 1. Increased numbers of GARP and CTLA-4 expressing Tregs in HCC patients.

Figure 1

Flow cytometric analysis was performed on PBMCs from HCC patients (n=23) and healthy controls (n=20). (A, B) Representative staining from an individual HCC patient and normal healthy donor for the frequency of CD3+CD4+Foxp3+ T cells. (C) Frequency and (D) absolute number of cells/ml of CD4+Foxp3+ Tregs in peripheral blood of HCC patients and normal healthy subjects. (E, F) Representative staining of GARP on CD3+CD4+Foxp3+ T cells. (G) Frequency of GARP+ Tregs and (H) GARP expression levels measured by mean fluorescent intensity (MFI) on Tregs. (I, J) Representative staining of CTLA-4 on CD3+CD4+Foxp3+ T cells. (K) Frequency of CTLA-4+ Tregs and (L) CTLA-4 expression levels. Each symbol represents an individual HCC patient (Inline graphic) or normal healthy subjects (Inline graphic); lines represent median values for the group. * P < 0.05, ** P < 0.01, *** P < 0.001, Mann-Whitney U test; † P < 0.05 Hochberg adjustment for multiple comparison.